MOSCOW (Reuters) – Russia’s health ministry has registered the one-shot Sputnik-Light version of its COVID-19 vaccine for use, the TASS news agency reported on Monday.
Russia said last week that it had completed clinical trials for the slimmed-down vaccine, which it has cast as a possible temporary solution to help countries with high infection rates make the vaccine go further.
Moscow has said that its two-dose Sputnik V vaccine will remain the main version used in Russia.
(Reporting by Gabrielle Tétrault-Farber; Editing by Kevin Liffey)